Obsessive-Compulsive Disorder Clinical Trial

Aim

Obsessive Compulsive Disorder (OCD) affects around 2% of the Australian population. The symptoms and features of OCD can vary greatly. The causes are not fully understood, but it is likely a combination of lifestyle and biological factors.

Our researchers are embarking on this clinical trial for a possible OCD treatment, which will restore the neural connections in the brain, and they are seeking participants.

Researchers are testing a new intervention for OCD symptoms. The trial aims to assess whether transcranial magnetic stimulation (TMS) can be used to balance altered communication between brain regions and improve OCD symptoms.

Participation involves

 The trial involves use of transcranial magnetic stimulation (TMS), which allows for the safe and non-invasive adjustment of brain activity.

Participants are required to attend 24 study site visits over six weeks, along with a 25^th visit after six months.

Participants will be offered parking/transport vouchers (up to $40 AUD per visit).

Eligibility criteria 

• Men and women between the ages of 18 and 50 years old
• Have had an OCD diagnosis for a period longer than 12 months
• Are able to attend 24 visits at the study site in Brisbane within a period of approximately six weeks, with a 25th follow up visit six months later

Your Rights

• Participation is completely voluntary
• If you decide to participate in the study and later feel that you no longer wish to be part of it, you may withdraw at any time without affecting any future health care
• Your records relating to this study and any other information received will be kept strictly confidential, except as required by the law.
• Qualified health professionals will monitor your health as it relates to the study.